Association of mild hyperhomocysteinemia with cardiac graft vascular disease.
In non-transplant patients mild hyperhomocysteinemia is an independent risk factor for vascular disease. The aim of this study was to determine whether hyperhomocysteinemia is associated with graft vascular disease. Fasting total plasma homocysteine was assessed in 18 patients with graft vasculopathy and 18 transplanted patients without graft vasculopathy matched for age, sex and the time since transplant. All were on cyclosporin. Graft vasculopathy was defined at coronary angiography as stenoses > or = 25%, or aneurysms. We found that hyperhomocysteinemia ( > or = 15 micromol/l) is common among transplanted heart recipients and significantly more frequent in the patients with graft vasculopathy (17/18 versus 11/18). Accordingly, the mean homocysteinemia was significantly higher in the group with graft vasculopathy (23.6+/-7.8 versus 16.9+/-7.1 micromol/l, P=0.01). The elevation of homocysteine plasma levels in the heart transplant recipients has probably multiple causes. The main cause seems to be renal failure. Additional causes could be azathioprine treatment or genetic polymorphisms. These results suggest that besides the immunological factors, homocysteine can play an additional role in the pathogenesis of graft vascular disease.
Cardiac Transplant Unit, Hôpital de la Timone, Marseille, France.
P
P
Ambrosi
D
D
Garçon
A
A
Riberi
G
G
Habib
A
A
Barlatier
B
B
Kreitmann
P H
PH
Rolland
G
G
Bouvenot
R
R
Luccioni
D
D
Métras
D000328:Adult; D016022:Case-Control Studies; D003327:Coronary Disease / Q000097:blood / Q000209:etiology*; D016027:Heart Transplantation; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D008875:Middle Aged; D012307:Risk Factors
D006710:Homocysteine